GLP-1 Receptor Agonist in Non-obese Patients with Type-2 Diabetes Mellitus and Heart Failure with Preserved Ejection Fraction

By sjmartinez • December 13, 2024

Khadke S, Kumar A, Bhatti A, Dani SS, Al-Kindi S, Nasir K, Virani SS, Upadhyay J, Garcia-Banigan DC, Abraham S, Husami R, Kong Y, Labib S, Venesy D, Shah S, Lenihan D, Vaduganathan M, Deswal A, Fonarow GC, Butler J, Nohria A, Kosiborod MN, Ganatra S. GLP-1 Receptor Agonist in Non-obese Patients with Type-2 Diabetes Mellitus and Heart Failure with Preserved Ejection Fraction. J Card Fail. 2024 Dec 10:S1071-9164(24)00962-X. doi: 10.1016/j.cardfail.2024.10.448. Epub ahead of print. PMID: 39667523.

Tags: Cardiology/Epi, GLP-1R agonists, Heart failure with preserved ejection fraction, Publications, SGLT 2 inhibitors

The Association of Menopausal Age with Sex Hormones and Anthropometric Measures Among Postmenopausal Women in the Multi-Ethnic Study of Atherosclerosis Study

Ebong IA, Wilson M, Racette SB, Appiah D, Schreiner PJ, Allison M, Watson K, Bertoni AG, Michos ED. The Association of Menopausal Age with Sex[...]

Ventricular tachycardia ablation across age groups: Outcomes, trends and demographics. Insights from the National Inpatient Sample Database

Morcos R, Malik S, Hanna P, Barakat A, Al Taii H, Di Biase L, Winterfield J, Vijayaraman P, Pokharel P. Ventricular tachycardia ablation across age[...]

SGLT2i and Primary Prevention of Cancer Therapy-Related Cardiac Dysfunction in Patients With Diabetes

Bhatti AW, Patel R, Dani SS, Khadke S, Makwana B, Lessey C, Shah J, Al-Husami Z, Yang EH, Thavendiranathan P, Neilan TG, Sadler D, Cheng[...]